Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erhard Seifried

Showing results (111-120 of 189) with videos related to

Pageof 19
Sort By:
Blood Transfusion = Trasfusione Del Sangue|October 29, 2015
Blood donor selection in European Union directives: room for improvementWim De Kort, Wolfgang Mayr, Christof Jungbauer, et al.
Journal of Translational Medicine|April 10, 2019
Quantitation of progenitor cell populations and growth factors after bone marrow aspirate concentrationRichard Schäfer, Malcolm R DeBaun, Erika Fleck, et al.
Blood|October 28, 2011
Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in micePeter Milanov, Lacramioara Ivanciu, Daniela Abriss, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|June 27, 2013
Validation of Virus NAT for HIV, HCV, HBV and HAV Using Post-Mortal Blood SamplesKnut Gubbe, Yvonne Scharnagl, Steffi Grosch, et al.
Cytotherapy|March 4, 2018
Generation of alloreactivity-reduced donor lymphocyte products retaining memory function by fully automatic depletion of CD45RA-positive cellsNina Müller, Katharina Landwehr, Kirsten Langeveld, et al.
BMC Health Services Research|May 1, 2015
Safety and effectiveness of a Patient Blood Management (PBM) program in surgical patients--the study design for a multi-centre prospective epidemiologic non-inferiority trialPatrick Meybohm, Dania Patricia Fischer, Christof Geisen, et al.
Blood Cells, Molecules & Diseases|November 6, 2004
IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantationUlrike Koehl, Jan Sörensen, Ruth Esser, et al.
Cytotherapy|October 8, 2013
Treatment of patients with advanced cancer with the natural killer cell line NK-92Torsten Tonn, Dirk Schwabe, Hans G Klingemann, et al.
Oncotarget|October 27, 2017
Hematopoietic transcription factors and differential cofactor binding regulate <i>PRKACB</i> isoform expressionOlga N Kuvardina, Stefanie Herkt, Annekarin Meyer, et al.
Journal of Translational Medicine|March 18, 2016
Automation of cellular therapy product manufacturing: results of a split validation comparing CD34 selection of peripheral blood stem cell apheresis product with a semi-manual vs. an automatic procedureChristiane Hümmer, Carolin Poppe, Milica Bunos, et al.
Pageof 19

Showing results (111-120 of 189) with videos related to

Sort By:
Pageof 19
Blood Transfusion = Trasfusione Del Sangue|October 29, 2015
Blood donor selection in European Union directives: room for improvementWim De Kort, Wolfgang Mayr, Christof Jungbauer, et al.
Journal of Translational Medicine|April 10, 2019
Quantitation of progenitor cell populations and growth factors after bone marrow aspirate concentrationRichard Schäfer, Malcolm R DeBaun, Erika Fleck, et al.
Blood|October 28, 2011
Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in micePeter Milanov, Lacramioara Ivanciu, Daniela Abriss, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|June 27, 2013
Validation of Virus NAT for HIV, HCV, HBV and HAV Using Post-Mortal Blood SamplesKnut Gubbe, Yvonne Scharnagl, Steffi Grosch, et al.
Cytotherapy|March 4, 2018
Generation of alloreactivity-reduced donor lymphocyte products retaining memory function by fully automatic depletion of CD45RA-positive cellsNina Müller, Katharina Landwehr, Kirsten Langeveld, et al.
BMC Health Services Research|May 1, 2015
Safety and effectiveness of a Patient Blood Management (PBM) program in surgical patients--the study design for a multi-centre prospective epidemiologic non-inferiority trialPatrick Meybohm, Dania Patricia Fischer, Christof Geisen, et al.
Blood Cells, Molecules & Diseases|November 6, 2004
IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantationUlrike Koehl, Jan Sörensen, Ruth Esser, et al.
Cytotherapy|October 8, 2013
Treatment of patients with advanced cancer with the natural killer cell line NK-92Torsten Tonn, Dirk Schwabe, Hans G Klingemann, et al.
Oncotarget|October 27, 2017
Hematopoietic transcription factors and differential cofactor binding regulate <i>PRKACB</i> isoform expressionOlga N Kuvardina, Stefanie Herkt, Annekarin Meyer, et al.
Journal of Translational Medicine|March 18, 2016
Automation of cellular therapy product manufacturing: results of a split validation comparing CD34 selection of peripheral blood stem cell apheresis product with a semi-manual vs. an automatic procedureChristiane Hümmer, Carolin Poppe, Milica Bunos, et al.
Pageof 19